Health anxiety and hypochondriasis in the light of DSM-5

Cite This

Files in this item

Checksum: MD5:2e9d06da753a26b6d5e5bcbe11cfd52a

BAILER, Josef, Tobias KERSTNER, Michael WITTHÖFT, Carsten DIENER, Daniela MIER, Fred RIST, 2016. Health anxiety and hypochondriasis in the light of DSM-5. In: Anxiety, Stress, & Coping. 29(2), pp. 219-239. ISSN 1061-5806. eISSN 1477-2205. Available under: doi: 10.1080/10615806.2015.1036243

@article{Bailer2016Healt-45246, title={Health anxiety and hypochondriasis in the light of DSM-5}, year={2016}, doi={10.1080/10615806.2015.1036243}, number={2}, volume={29}, issn={1061-5806}, journal={Anxiety, Stress, & Coping}, pages={219--239}, author={Bailer, Josef and Kerstner, Tobias and Witthöft, Michael and Diener, Carsten and Mier, Daniela and Rist, Fred} }

Diener, Carsten Witthöft, Michael Health anxiety and hypochondriasis in the light of DSM-5 Bailer, Josef Witthöft, Michael Rist, Fred Kerstner, Tobias 2019-02-28T08:11:35Z Mier, Daniela Background: In the DSM-5, the diagnosis of hypochondriasis was replaced by two new diagnositic entities: somatic symptom disorder (SSD) and illness anxiety disorder (IAD). Both diagnoses share high health anxiety as a common criterion, but additonal somatic symptoms are only required for SSD but not IAD.<br /><br />Design: Our aim was to provide empirical evidence for the validity of these new diagnoses using data from a case–control study of highly health-anxious (n = 96), depressed (n = 52), and healthy (n = 52) individuals.<br /><br />Results: The individuals originally diagnosed as DSM-IV hypochondriasis predominantly met criteria for SSD (74%) and rarely for IAD (26%). Individuals with SSD were more impaired, had more often comorbid panic and generalized anxiety disorders, and had more medical consultations as those with IAD. Yet, no significant differences were found between SSD and IAD with regard to levels of health anxiety, other hypochondriacial characteristics, illness behavior, somatic symptom attributions, and physical concerns, whereas both groups differed significantly from clinical and healthy controls in all of these variables.<br /><br />Conclusion: These results do not support the proposed splitting of health anxiety/hypochondriasis into two diagnoses. Further validation studies with larger samples and additional control groups are warranted to prove the validity of the new diagnoses. Rist, Fred 2019-02-28T08:11:35Z Mier, Daniela eng terms-of-use 2016 Bailer, Josef Diener, Carsten Kerstner, Tobias

Downloads since Feb 28, 2019 (Information about access statistics)

Bailer_2-iqd411m32r1n0.pdf 1373

This item appears in the following Collection(s)

Search KOPS


My Account